AISight Dx
door PathAI
AISight Dx is PathAI's digital pathology platform and image management system for pathology laboratories and academic centres. The vendor says pathologists use it to view, interpret, share and manage whole-slide images, and that AI runs inside the slide viewer: PathAI's own workflow algorithms for quality control, prioritising cases in which suspicious tissue is found and assessing tumour cellularity before sequencing, plus more than 40 third-party algorithms, for example for PD-L1, HER2, Ki-67 and other biomarkers, each with its own regulatory status. The vendor says its automated case review, assisted diagnosis, reporting and finalisation features are research-use only and not for primary diagnosis, so the diagnosis stays with the pathologist reading the slides. It describes the platform as cloud-native, and for a European deployment announced in 2025 says all data storage and processing remain within Europe; its general privacy notice says its platforms are operated and hosted from the United States.
Transparantiescore
Gewogen over vier pijlers · bijgewerkt October 20, 2026
Functionaliteiten
Leveranciersinformatie
Volledige informatie over de leverancier/provider van deze AI-applicatie
Leveranciersinformatie volgens de EU AI Act
Potentiële risico's
1 aandachtspunten geïdentificeerd
Beoordeling aanbevolen vóór gebruik
Deze aandachtspunten worden automatisch geïdentificeerd op basis van openbaar beschikbare informatie over de leverancier en AI-catalogusgegevens. Werkelijke risico's kunnen variëren afhankelijk van uw specifieke use case en implementatie.
Krijg inzicht in risico's door beoordelingen uit te voeren op deze AI-applicatie.
Werk je bij PathAI? Claim deze vermelding om de gegevens te corrigeren of aan te vullen.
Klaar om AI-applicaties te beheren?
Volg, beoordeel en beheer je AI-applicaties met Anove.